AzTrials
AzTrials

Smoking CessationNCT01686178

Countering Young Adult Tobacco Marketing in Bars

A study testing Anti-smoking social marketing campaign in people with Smoking Cessation, run by University of California, San Francisco at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of the study is to implement and evaluate interventions to decrease smoking among young adults attending bars and nightclubs. It is believed that the proportion of young adult current smokers during and after the intervention will be significantly less than the proportion of young adult smokers before the… Read more about this study

Who is it for?
Ages 18 to 26 yearsHealthy volunteers can take part
Conditions the study is for
Smoking Cessation
What is being tested?
Anti-smoking social marketing campaign
Could I receive a placebo?
No, everyone receives an active treatment
How many people
17,422 participants
Where
1 siteUnited States
Study dates
Sep 2012to 2 Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 26 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Participants are healthy volunteers 18-26 years old currently living in San Diego, Portland, Albuquerque, Oklahoma, San Francisco/Bay Area, Nashville, Tucson, or Los Angeles who attend bars or nightclubs
  • Able to read, speak, and understand English
  • NOTE: PARTICIPANTS CAN ONLY TAKE PART IN THE STUDY BY ENCOUNTERING STUDY SURVEY TEAMS OUT AT BARS OR NIGHTCLUBS IN ONE OF THE STUDY CITIES LISTED ABOVE. PARTICIPANTS CANNOT SIGN UP FOR THE STUDY BY CALLING OR EMAILING.

Who cannot join

  • Out of age range (18-26 years old)
  • Not living in San Diego, Portland, Albuquerque, Oklahoma, San Francisco/Bay Area, Nashville, Tucson, Los Angeles or New York City, or currently attending college outside of the target cities.
  • Unable to read, speak, or understand English.
  • Unwillingness or inability to participate or give informed consent.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of California, San Francisco

    San Francisco, California, 94530

Other trials in United States

About this study

The goal of the study is to implement and evaluate interventions to decrease smoking among young adults attending bars and nightclubs. It is believed that the proportion of young adult current smokers during and after the intervention will be significantly less than the proportion of young adult smokers before the intervention in each of the study cities.

Being tested
Anti-smoking social marketing campaign
Keywords
Smoking, Smoking Cessation, Tobacco Use Cessation, Social Networks, Social Control, Informal
Medical subject headings
Smoking Cessation, Smoking, Tobacco Use Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anti-smoking social marketing campaignBehavioural

    We will utilize industry market research tools to define the target audience (segment of community with high smoking prevalence and high social influence) and directly counter tobacco industry lifestyle marketing strategies through local promotion of a smokefree brand and branded bar and club events.

Study groups in NCT01686178
Study groupRoleWhat they receive
Anti-smoking social marketing campaignExperimentalIn prior research, a high risk subpopulation of young adults was identified in San Diego, CA: the "hipster" subculture. We developed a yearlong pilot social branding intervention to decrease smoking among this group, using social events and social leaders to promote a strong nonsmoking lifestyle. The intervention rationale is based on utilizing industry market research tools to define the target audience and directly countering tobacco industry lifestyle marketing strategies. We now propose to extend this intervention to three other cities (tailoring the intervention to a high-risk subpopulation of young adults in each city) and evaluate it in a multicenter quasi-experimental controlled trial.
Receives: Behavioral: Anti-smoking social marketing campaign
ControlNo interventionSurvey research data will be collected in control cities with the same schedule as data collection in the cities where the intervention is taking place.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-Reported Tobacco Smoking in past 30 days

    The main outcome measure for this analysis will be the proportion of current smoking, defined as self-reported smoking on one or more of the past 30 days.

    Measured: Between baseline and follow-up at 1,2, & 3 years post-baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2012 (estimated)
  2. Study startSep 2012
  3. Primary completion2 Jul 2017
  4. Study completion2 Jul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
17,422 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01686178
Sponsor's protocol ID
1U01CA154240-05
Status last verified
Oct 2017
First submitted
12 Sep 2012
Last updated
18 Oct 2017
Results posted
No
Data monitoring committee
No

Publications

  • Ling PM, Glantz SA. Using tobacco-industry marketing research to design more effective tobacco-control campaigns. JAMA. 2002 Jun 12;287(22):2983-9. doi: 10.1001/jama.287.22.2983.

    PubMed 12052128
  • Ling PM, Lisha NE, Neilands TB, Jordan JW. Join the Commune: A Controlled Study of Social Branding Influencers to Decrease Smoking Among Young Adult Hipsters. Am J Health Promot. 2020 Sep;34(7):754-761. doi: 10.1177/0890117120904917. Epub 2020 Feb 20.

    PubMed 32077305
  • Lisha NE, Jordan JW, Ling PM. Peer crowd affiliation as a segmentation tool for young adult tobacco use. Tob Control. 2016 Oct;25(Suppl 1):i83-i89. doi: 10.1136/tobaccocontrol-2016-053086.

    PubMed 27697952

Questions about this trial

What is this clinical trial studying?

A study testing Anti-smoking social marketing campaign in people with Smoking Cessation, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-Reported Tobacco Smoking in past 30 days (time frame: Between baseline and follow-up at 1,2, & 3 years post-baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01686178, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in